# Eucalyptus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eucalyptus

- Industry: Healthcare IT
- Headquarters: Sydney, Australia
- Website: www.eucalyptus.health/
- Total disclosed funding: $72M
- Latest round: Series C (Jan 27, 2022)
- Investors on record: 8

## About

Eucalyptus is an Australian-based digital healthcare company that delivers patient-centered healthcare solutions through various telehealth services across reproductive health, men's health, women's weight management, and skincare. Founded in 2019 in Sydney, Australia, Eucalyptus is a digital healthcare provider focused on delivering tailored telehealth services. In February 2026, Hims & Hers Health, Inc., a portfolio company of Institutional Venture Partners, Redpoint Ventures, Forerunner Ventures, SV Angel, Maverick Capital, Thrive Capital, Cherubic Ventures, Thrive Capital Partners, Atomic Management, Amity Supply, 7GC, Disruptive Technology Ventures, NewView Capital, and Gorilla Private Equity agreed to acquire Eucalyptus from Blackbird, Comcast Ventures, W23, OneVentures, AirTree Ventures, NewView Capital, Athletic Ventures, and Bond. The acquisition totaled USD 1.15 billion. The firm was co-founded by Benny Kleist, Charlie Gearside, and Tim Doyle, who have a history of entrepreneurial ventures in healthcare. Eucalyptus specializes in digital healthcare solutions that prioritize patient-centric care across various domains, including reproductive health, men's health, women's weight management, and skincare. The company operates several digital clinics, such as Kin, Pilot, Juniper, Compound, and Software, which provide tailored telehealth services and treatment plans. Kin, launched in 2020, offers comprehensive reproductive healthcare services, including fertility care and contraceptive pill delivery, serving over 50,000 subscribers. Pilot, established in 2019, addresses men's health issues like erectile dysfunction and hair loss, while Juniper, founded in 2021, empowers women with personalized weight management programs. Compound focuses on preventative health and performance for men, and Software delivers bespoke skincare formulations. Eucalyptus operates in diverse markets including Australia, the UK, Japan, and Germany. Eucalyptus generates revenue through various channels, including direct-to-consumer subscriptions and partnerships. Clients engage with the company via subscription-based services for fertility care, contraceptive delivery, and weight management programs, ensuring ongoing access to healthcare solutions. For instance, Kin’s contraceptive delivery service operates on a subscription model, creating a steady revenue stream by charging customers for monthly deliveries. Additionally, services under Pilot and Juniper involve individualized treatment plans catering to specific health needs and goals, enhancing user engagement and retention. The company also capitalizes on retail partnerships, particularly with its skincare line, which is available in outlets such as Priceline Pharmacy, broadening its customer reach and revenue potential. The February 2026 acquisition will enable Hims & Hers to expand into Australia and Japan, deepen its presence in the UK, Germany, and Canada, and use Eucalyptus’ local teams and infrastructure to scale its international telehealth operations.

## Funding rounds

- Series C, Jan 27, 2022, $42M — OneVentures, Blackbird, AirTree Ventures, NewView Capital, Bond, W23, Athletic Ventures
- Series B, Jul 13, 2021, $22M — Blackbird, AirTree Ventures, NewView Capital, W23
- Series A, May 21, 2020, $8M — Comcast Ventures, Blackbird, W23
- Seed, Oct 31, 2019 — Blackbird

## Investors

- Blackbird (https://capitalatlas.ai/funds/blackbird) — Seed, Series A, Series B, Series C
- Comcast Ventures (https://capitalatlas.ai/funds/comcast-ventures) — Series A
- W23 (https://capitalatlas.ai/funds/w23) — Series A, Series B, Series C
- AirTree Ventures (https://capitalatlas.ai/funds/airtree-ventures) — Series B, Series C
- NewView Capital (https://capitalatlas.ai/funds/newview-capital) — Series B, Series C
- OneVentures (https://capitalatlas.ai/funds/oneventures) — Series C
- Bond (https://capitalatlas.ai/funds/bond) — Series C
- Athletic Ventures (https://capitalatlas.ai/funds/athletic-ventures) — Series C